By NextBestFitPhase 5: Stabilize & govern · Step 5.3
Run an independent evaluation and the Year-10 review
Annual reports; Year 10 vote · Independent evaluator (National Academies + GAO); CongressDiscuss this step
Pros & cons of this step
Pros
- +Turns contested predictions (waits, innovation, quality) into measured facts.
Cons
- −Scheduled reviews add uncertainty for providers and investors planning long-term.
- Accountability vs. stability.
medium confidence
Quality of care and health outcomes
Coverage improves outcomes for the previously uninsured and underinsured. For the already well-insured, quality is unlikely to change much. Waits could harm outcomes if they become long for time-sensitive care.
Today
The U.S. ranks last among 10 high-income countries in the Commonwealth Fund's 2024 comparison, and has the lowest life expectancy among peers.Under the plan
Universal access to primary care and medications; single dataset for quality measurement.Who gains
- The previously uninsured (mortality reductions estimated in Medicaid expansion studies)
Who loses
- Possibly patients facing longer waits for elective procedures
Magnitude: Studies estimate thousands to tens of thousands of lives saved per year (Galvani et al. estimated 68,000; estimates vary widely).
- Commonwealth FundU.S. last overall among 10 countries.Sources: The Commonwealth Fund (2024)
- Lancet (Galvani 2020)Estimated about 68,000 lives saved per year; advocacy-aligned and at the high end.Sources: Galvani et al., The Lancet (2020)
Mitigations
- Quality withholds in global budgets
- Public quality reporting
Risk that remains: Life expectancy depends heavily on non-medical factors (obesity, overdoses, guns, cars) that coverage doesn't fix.